首页 | 本学科首页   官方微博 | 高级检索  
     


Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways
Authors:Pandi-Perumal Seithikurippu R  Trakht Ilya  Srinivasan Venkataramanujan  Spence D Warren  Maestroni Georges J M  Zisapel Nava  Cardinali Daniel P
Affiliation:Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, Room #BB813, NY 10032, USA. sleepresearch@gmail.com
Abstract:Melatonin, an endogenous signal of darkness, is an important component of the body's internal time-keeping system. As such it regulates major physiological processes including the sleep wake cycle, pubertal development and seasonal adaptation. In addition to its relevant antioxidant activity, melatonin exerts many of its physiological actions by interacting with membrane MT1 and MT2 receptors and intracellular proteins such as quinone reductase 2, calmodulin, calreticulin and tubulin. Here we review the current knowledge about the properties and signaling of melatonin receptors as well as their potential role in health and some diseases. Melatonin MT1 and MT2 receptors are G protein coupled receptors which are expressed in various parts of the CNS (suprachiasmatic nuclei, hippocampus, cerebellar cortex, prefrontal cortex, basal ganglia, substantia nigra, ventral tegmental area, nucleus accumbens and retinal horizontal, amacrine and ganglion cells) and in peripheral organs (blood vessels, mammary gland, gastrointestinal tract, liver, kidney and bladder, ovary, testis, prostate, skin and the immune system). Melatonin receptors mediate a plethora of intracellular effects depending on the cellular milieu. These effects comprise changes in intracellular cyclic nucleotides (cAMP, cGMP) and calcium levels, activation of certain protein kinase C subtypes, intracellular localization of steroid hormone receptors and regulation of G protein signaling proteins. There are circadian variations in melatonin receptors and responses. Alterations in melatonin receptor expression as well as changes in endogenous melatonin production have been shown in circadian rhythm sleep disorders, Alzheimer's and Parkinson's diseases, glaucoma, depressive disorder, breast and prostate cancer, hepatoma and melanoma. This paper reviews the evidence concerning melatonin receptors and signal transduction pathways in various organs. It further considers their relevance to circadian physiology and pathogenesis of certain human diseases, with a focus on the brain, the cardiovascular and immune systems, and cancer.
Keywords:AANAT, arylalkylamine-N-acetyl transferase   AD, Alzheimer's disease   AFMK, N1-acetyl-N2-formyl-5-methoxykynuramine   AMMTC, N-acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole   IL, interleukin   cAMP, 3′,5′-cyclic adenosine monophosphate   cGMP, 3′,5′-cyclic guanosine monophosphate   CREB, cyclic AMP responsive element binding   CRSD, circadian rhythm sleep disorders   DA, dopamine   DSPS, delayed sleep phase syndrome   ER, estrogen receptor   GABA, γ-aminobutyric acid   GnRH, gonadotropin-releasing hormone   GPR, G protein receptor   GTP, guanosine triphosphate   HIOMT, hydroxyindole-O-methyltransferase   LH, luteinizing hormone   NE, norepinephrine   NK, natural killer   PKC, protein kinase C   PT, pars tuberalis   RGCs, retinal ganglion cells   RGS, regulator of G protein signaling   RPE, retinal pigment epithelium   SCN, suprachiasmatic nucleus
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号